Replimune Group Inc

NASDAQ:REPL  
6.45
-0.52 (-7.46%)
7:57:53 PM EDT: $6.53 +0.08 (+1.24%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Replimune Group Inc Stock, NASDAQ:REPL

500 Unicorn Park Drive, Suite 303, Woburn, Massachusetts 01801
United States of America
Phone: +1.781.222.9600
Number of Employees: 284
http://www.replimune.com

Description

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.